Achieving high and equitable coverage of adolescent HPV vaccine in Scotland

Journal of Epidemiology and Community Health

Volumn 68, Issue 1, 2014, Pages 57-63

  Sinka, Katy ^a   Kavanagh, Kimberley ^b   Gordon, Ruth ^c   Love, John ^a   Potts, Alison ^a   Donaghy, Martin ^a   Robertson, Chris ^a,b,d  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c INFORMATION SERVICES DIVISION   (United Kingdom)

^d INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; BIOLOGICAL UPTAKE; DATA SET; IMMUNE SYSTEM; NUMERICAL MODEL; POPULATION STRUCTURE; VACCINATION;

SCOTLAND; UNITED KINGDOM;

HUMAN PAPILLOMAVIRUS;

WART VIRUS VACCINE;

ADOLESCENT; ADOLESCENTS CG; ARTICLE; CANCER: CERVIX; CHILD; FEMALE; HUMAN; IMMUNIZATION; INEQUALITIES; ORGANIZATION AND MANAGEMENT; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; SCHOOL HEALTH SERVICE; STATISTICS; UNITED KINGDOM; UTERINE CERVIX TUMOR; VIROLOGY;

ADOLESCENTS CG; CANCER: CERVIX; IMMUNIZATION; INEQUALITIES; PUBLIC HEALTH;

ADOLESCENT; CHILD; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SCHOOL HEALTH SERVICES; SCOTLAND; UTERINE CERVICAL NEOPLASMS;

EID: 84890314064     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2013-202620     Document Type: Article

References (27)

1. Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008;337:a769.
2. Jit M, Chapman R, Hughes O, et al. Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model. BMJ 2011;343:d5775.
3. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008;336:1056-8.
4. Kumar VM, Whynes DK. Explaining variation in the uptake of HPV vaccination in England. BMC Public Health 2011;11:172.
5. Desai S, Soldan K, White J, et al. Human papillomavirus vaccine coverage. Lancet 2010;376:328-9.
6. Fisher H, Audrey S, Mytton JA, et al. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. J Public Health (Oxf) 2013. Published online First: 25 April 2013 doi:10.1093/pubmed/fdt042
7. Office of the Chief Statistician. Scottish Index of Multiple Deprivation 2009. Technical Report. 2009.
8. The Scottish Government. School Education Datasets. http://www.scotland.gov.uk/Topics/Statistics/Browse/School-Education/Datasets
9. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2001.
10. Ritchie LD. Meningococcal Group C Immunisation Programme 1999-2001: Final Report. 2001. http://www.documents.hps.scot.nhs.uk/immunisation/meningitis-and-septicaemia/men-c-prog-scot.pdf
11. Wallace LA, Bramley JC, Ahmed S, et al. Determinants of universal adolescent hepatitis B vaccine uptake. Arch Dis Child 2004;89:1041-2.
12. Cameron JC, Wallace LA, Ahmed S, et al. HPV vaccine: positive insights from universal adolescent HepB vaccination. J. Epidemiol Community Health 2007;61:1018-19.
13. Rondy M, van Lier A, van de Kassteele J, et al. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine 2010;28:2070-5.
14. GPs not told of school HPV opt-outs. GP Magazine, July 2012. http://www.gponline.com/News/article/1141051
15. Marlow LA, Wardle J, Forster AS, et al. Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Community Health 2009;63:1010-15.
16. Brabin L, Roberts SA, Farzaneh F, et al. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006;24:3087-94.
17. Roberts SA, Brabin L, Stretch R, et al. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect 2011;139:400-5.
18. Boyce T, Holmes A. Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse. PLoS ONE 2012;7:e43416.
19. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:671-7.
20. European Centre for Disease Prevention and Control. Introduction of HPV vaccines in European Union countries-an update. 2012.
21. National Services Scotland Information Services Division. HPV Immunisation Uptake Statistics for the Catch-up Programme September 2008-31 August 2011. 2012. http://www.isdscotland.org/Health-Topics/Child-Health/Publications/2012-09-25/2012-09-25-HPV-Catchup-Report.pdf
22. Kreimer AR, Rodriguez AC, Hildesheim A, et al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst 2011;103:1444-51.
23. O'Leary MC, Sinka K, Robertson C, et al. HPV type-specific prevalence using a urine assay in unvaccinated male and female 11-to 18-year olds in Scotland. Br J Cancer 2011;104:1221-6.
24. Brabin L, Greenberg DP, Hessel L, et al. Current issues in adolescent immunization. Vaccine 2008;26:4120-34.
25. Middleman AB, Tung JS. At what sites are parents willing to have their 11 through 14-year-old adolescents immunized? Vaccine 2010;28:2674-8.
26. National Services Scotland Information Services Division. Cancer of the cervix uteri (ICD-10 C53) Scotland: age-standardised incidence and mortality rates (EASRs), by SIMD 2009. 2012. http://www.isdscotland.org/Health-Topics/Cancer/Publications/2012-10-30/dim_cancer_cervix.xls?1
27. Friederichs V, Cameron JC, Robertson C. Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987-2004. Arch Dis Child 2006;91:465-8.